Clinical application of dexmedetomidine in painless gastrointestinal endoscopy

Clinical application of dexmedetomidine in endoscopic retrograde cholangiopancreatography

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043392

Enrollment

Unknown

Registered

2021-02-13

Start date

2021-02-18

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive tract diseases

Interventions

Group 1:Dexmedetomidine, nasal drip

Group 2:Dexmedetomidine, Intravenous pumping

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Aged 18-75 years, normal health, ASA grade II-III, no history of organic digestive system diseases, no history of heart, liver, renal insufficiency, cerebrovascular accidents and other medical diseases.

Exclusion criteria

Exclusion criteria: History of allergy and addiction to opioids and other narcotic drugs;Severe cardiopulmonary diseases, abnormal liver and kidney functions;Unable to cooperate and reject participants.

Design outcomes

Primary

Measure	Time frame
Blood pressure;	—

Countries

China

Contacts

Public ContactZhang Zhengzheng

Department of Anesthesiology, Wuxi People's Hospital

aniu1120@163.com+86 13961859520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026